ALGS vs EW · rev $3.6M vs P/E 47, rev $1.39B
Aligos Therapeutics Inc (ALGS) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
ALGS currently screens at market cap $44.1M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the ALGS and EW stock pages for the full models.
Not investment advice.